NHS to Offer Wegovy (Semaglutide) to Reduce Heart and Stroke Risk
A new life-changing treatment option – GLP-1 drug semaglutide known as Wegovy – is set to be available on the NHS within months, with 1.2 million people with cardiovascular disease eligible to receive the treatment to help prevent heart attacks and strokes over the next few years. People with heart and circulatory disease who are